Vyvanse 20 MG chewable tablet 100S
Ended Awarded Last action
- Contract number
- SPE2DR26F9KC0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,582
Award facts
- Contract value 100% obligated
- $10,582.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,582.25 to AmerisourceBergen Drug Corp for 100 units of Vyvanse 20 mg chewable tablets. This competitively awarded, non-set-aside contract was issued on January 7, 2026, with an ultimate completion date of January 8, 2026. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., serves as a critical pharmaceutical distributor for federal medical procurement needs across military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of prescription medications, generic drugs, vaccines, and medical supplies to support military healthcare programs worldwide. Vyvanse (lisdexamfetamine), a controlled-release stimulant medication commonly used to treat attention deficit hyperactivity disorder, represents one of the diverse pharmaceutical products delivered through this contract vehicle to the Defense Health Agency and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F9KC0?
SPE2DR26F9KC0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26F9KC0 worth?
The government has obligated $10,582 on SPE2DR26F9KC0.
Is contract SPE2DR26F9KC0 an order under another contract?
Yes. SPE2DR26F9KC0 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9KC0 competed?
The extent of competition for SPE2DR26F9KC0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award